Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects

By Stangier Joachim  

Clinical Pharmacokinetics, Vol. 47, Iss. 1, 2008-01 ,pp. : 47-59

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 188-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched white subjects

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 150-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population Pharmacokinetics Meta-Analysis of Recombinant Human Erythropoietin in Healthy Subjects

By Olsson-Gisleskog Per  

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 159-173

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

By Khosravan Reza   Grabowski Brian A.   Wu Jing-Tao   Joseph-Ridge Nancy   Vernillet Laurent  

Clinical Pharmacokinetics, Vol. 45, Iss. 8, 2006-01 ,pp. : 821-841

Adis International

Access to resources Recommend Favorite